This brief outlines some perspectives from the Institute of Health Economics (IHE) based on what we have heard from government, public agencies, and industry, and seeks to summarize the key areas where further clarification and deliberation could be helpful.
On November 1st, 2017, the Institute of Health Economics (IHE) hosted a pan-Canadian roundtable discussion regarding diabetes care and management in indigenous populations in Canada. This event was sponsored through an educational grant from Boehringer Ingelheim Canada, and was developed in consultation with an advisory committee including: Mr. Mehmood Alibhai (Boehringer Ingelheim…
On December 12th, 2016, the Institute of Health Economics (IHE) held a roundtable discussion regarding the role of real-world evidence (RWE) in decision-making in Canada, with a focus on RWE generated for pricing and reimbursement. The meeting brought together 11 representatives of key stakeholders: experts in evidence assessment, payers, and those generating RWE including academia…
In October 2015, we held the first Canadian consensus discussion that led to provisional recommendations regarding special considerations for policy-making and healthcare decisionmaking for interventions in patients with idiopathic pulmonary fibrosis (IPF). The meeting included 11 representatives of key stakeholders: patients, care providers, and policy researchers from across…
The federal Minister of Health, the Honourable Rona Ambrose, announced the creation of the Advisory Panel on Healthcare Innovation (Panel) on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s mandate is to identify promising innovations, here and internationally, which could help Canada reduce growth…
The purpose of this roundtable was to gather a small, select group of thought leaders to engage in informed discourse, which was summarized in a report submitted to the new federal Healthcare Innovation Advisory Panel. This roundtable, created in response to the Federal Healthcare Innovation Advisory Panel’s call for stakeholder input, was an exciting opportunity to…
The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies half-day invitational roundtable was part of the IHE's ongoing Methodology Forum series supported by the Institute of Health Economics, the Alberta government, and industry partners, AstraZeneca, Merck, and Eli Lilly. The event brought together academic experts, industry leaders and senior decision…
The Institute of Health Economics, in partnership with Alberta Enterprise and Advanced Education, Alberta Health, and Eli Lilly Canada, conducted a roundtable to examine the concept of Alberta Health as a Living Laboratory. The ‘Living Laboratory’ concept builds off the recognition of the unique assets and opportunity we have in Alberta, including a single health authority…
A National Roundtable Discussion on Innovative Approaches to Industry-Payor Agreements took place on April 3th, 2011 at the Fairmont Hotel Vancouver in Vancouver, British Columbia in association with the annual meeting of the Canadian Agency for Drugs and Technologies in Health (CADTH). This one-day invitational event engaged experts, industry leaders and senior decision makers…
The purpose of this paper is to provide background information on "game changing innovations" in support of the February 24, 2011 conference Becoming the Best: Building a Sustainable Health System – Game Changing Health Innovations. It was developed by the Institute of Health Economics and funded by Alberta Health Services (AHS) as part of a future focused analysis of the…